Fortress Biotech Inc (NASDAQ: FBIO) kicked off on Friday, up 6.61% from the previous trading day, before settling in for the closing price of $2.42. Over the past 52 weeks, FBIO has traded in a range of $1.33-$2.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 24.49%. While this was happening, its average annual earnings per share was recorded 70.63%. With a float of $21.26 million, this company’s outstanding shares have now reached $29.75 million.
Let’s determine the extent of company efficiency that accounts for 101 employees.
Fortress Biotech Inc (FBIO) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Fortress Biotech Inc is 28.55%, while institutional ownership is 17.17%. The most recent insider transaction that took place on May 29 ’25, was worth 129,000. In this transaction 10% Owner of this company sold 100,000 shares at a rate of $1.29, taking the stock ownership to the 6,122,249 shares. Before that another transaction happened on Sep 23 ’24, when Company’s PRESIDENT, CEO & CHAIRMAN bought 763,359 for $1.84, making the entire transaction worth $1,404,581. This insider now owns 3,657,264 shares in total.
Fortress Biotech Inc (FBIO) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.76 earnings per share (EPS), lower than consensus estimate (set at -0.27) by -0.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 70.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.86% during the next five years compared to 24.49% growth over the previous five years of trading.
Fortress Biotech Inc (NASDAQ: FBIO) Trading Performance Indicators
Take a look at Fortress Biotech Inc’s (FBIO) current performance indicators. Last quarter, stock had a quick ratio of 1.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.14, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Fortress Biotech Inc (FBIO)
Looking closely at Fortress Biotech Inc (NASDAQ: FBIO), its last 5-days average volume was 0.8 million, which is a jump from its year-to-date volume of 0.29 million. As of the previous 9 days, the stock’s Stochastic %D was 80.19%.
During the past 100 days, Fortress Biotech Inc’s (FBIO) raw stochastic average was set at 93.28%, which indicates a significant increase from 88.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.16 in the past 14 days, which was higher than the 0.11 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.98, while its 200-day Moving Average is $1.83. However, in the short run, Fortress Biotech Inc’s stock first resistance to watch stands at $2.69. Second resistance stands at $2.81. The third major resistance level sits at $2.94. If the price goes on to break the first support level at $2.44, it is likely to go to the next support level at $2.31. Should the price break the second support level, the third support level stands at $2.19.
Fortress Biotech Inc (NASDAQ: FBIO) Key Stats
The company with the Market Capitalisation of 76.77 million has total of 29,755K Shares Outstanding. Its annual sales at the moment are 57,680 K in contrast with the sum of -46,000 K annual income. Company’s last quarter sales were recorded 16,410 K and last quarter income was 15,490 K.
